← All companies
GRCE
Grace Therapeutics, Inc.
$2.08
+0.01 +0.48%
Key statistics
from XBRL data in SEC filingsMarket cap
—
Revenue (TTM)
—
Net income (TTM)
—
EPS (TTM)
—
P/E ratio
—
Dividend yield
—
Free cash flow
—
Cash
—
Total assets
—
Gross margin
—
52-week range
$1.79 – $5.18
Recent SEC filings
40 most recentAnnual, quarterly & current reports
8-K
Other events
Jul 28, 2026
8-K
Other events
Jun 18, 2026
8-K
Results of operations (earnings release)
Jun 18, 2026
10-K
Fiscal year ended 2026-03-31
Jun 18, 2026
8-K
Director or officer change
Jun 5, 2026
8-K
Other events
Apr 27, 2026
8-K
Other events
Apr 23, 2026
8-K
Results of operations (earnings release)
Feb 12, 2026
10-Q
Quarter ended 2025-12-31
Feb 12, 2026
8-K
Director or officer change
Jan 12, 2026
10-Q/A
Quarter ended 2025-09-30
Nov 17, 2025
8-K
Results of operations (earnings release); Other events
Nov 13, 2025
10-Q
Quarter ended 2025-09-30
Nov 13, 2025
8-K
Other events
Oct 23, 2025
8-K
Other events
Sep 18, 2025
8-K
Shareholder vote results
Sep 12, 2025
8-K
Other events
Aug 27, 2025
8-K
Results of operations (earnings release)
Aug 12, 2025
10-Q
Quarter ended 2025-06-30
Aug 12, 2025
8-K
Other events
Jun 25, 2025
8-K
Results of operations (earnings release)
Jun 23, 2025
10-K
Fiscal year ended 2025-03-31
Jun 23, 2025
8-K
Other events
Apr 9, 2025
8-K
Other events
Mar 3, 2025
10-Q/A
Quarter ended 2024-12-31
Feb 19, 2025
8-K
Results of operations (earnings release)
Feb 13, 2025
10-Q
Quarter ended 2024-12-31
Feb 13, 2025
8-K
Entered a material agreement; Unregistered sale of equity; Other events
Feb 10, 2025
8-K
Results of operations (earnings release)
Nov 13, 2024
10-Q
Quarter ended 2024-09-30
Nov 13, 2024
8-K
Amended charter or bylaws
Oct 28, 2024
8-K
Other events
Oct 25, 2024
8-K
Entered a material agreement; Modified rights of security holders; Amended charter or bylaws
Oct 7, 2024
8-K
Director or officer change; Shareholder vote results
Sep 30, 2024
8-K
Other events
Sep 25, 2024
8-K
Director or officer change
Aug 16, 2024
8-K
Results of operations (earnings release)
Aug 9, 2024
10-Q
Quarter ended 2024-06-30
Aug 9, 2024
8-K
Other events
Jun 27, 2024
8-K
Results of operations (earnings release)
Jun 21, 2024